Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.

British Journal of Clinical Pharmacology

Volumn 37, Issue 3, 1994, Pages 279-288

  Detry, JM ^a   Sellier, P ^a   Pennaforte, S ^a   Cokkinos, D ^a   Dargie, H ^a   Mathes, P ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROPRANOLOL; TRIMETAZIDINE;

ADULT; ADVERSE DRUG REACTION; AGED; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; ELECTROCARDIOGRAM; EXERCISE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY;

ANGINA PECTORIS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROPRANOLOL; REPRODUCIBILITY OF RESULTS; TRIMETAZIDINE;

EID: 0028359703     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1994.tb04276.x     Document Type: Article

References (33)

1. New anti‐ischaemic drugs: cytoprotective action with no primary haemodynamic effects
2. Determination en simple insu contre placebo de la relation dose/activité du Vastarel 20 mg dans l'insuffisance coronarienne chronique
3. Effets de la trimétazidine sur les paramètres ergométriques dans l'angor d'effort. Etude multicentrique contrôlée à double insu contre placebo
4. Acute effects of trimetazidine evaluated by exercise testing
5. The efficacy of trimetazidine in stable effort angina. A double blind placebo controlled study
6. Comparison of trimetazidine with nifedipine in effort angina: a double‐blind, crossover study
7. Tissue distribution after intravenous administration of trimetazidine in dogs
8. Direct antiischemic effect of trimetazidine during coronary angioplasty (PTCA)
9. Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine
10. Therapeutic value of a cardioprotective agent in patients with severe ischemic cardiogopathy
11. Cardioprotective effect of trimetazidine during coronary artery graft surgery
12. Trimetazidine, a cellular antiischemic agent
13. Etude de la captation et de la distribution de la trimetazidine dans les globules rouges et le muscle lisse
14. An examination of the possible pharmacokinetic interaction of trimetazidine with theophylline, digoxin and antipyrine
15. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organisation task force on standardization of clinical nomenclature
16. Grading of angina pectoris
17. A new semiautomated algorithm to quantify holter‐detected myocardial ischemia: preliminary experience in the Trimetazidine European Multicenter Trial (TEMS)
18. The rate pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris
19. Cardioprotective effect of trimetazidine and nifedipine in guinea‐pig hearts subjected to ischemia
20. Effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease
21. Cardioprotection by calcium antagonists, piridoxilate and trimetazidine
22. Anti‐ischaemic effects of trimetazidine: 31P‐NMR spectroscopy in the isolated rat heart
23. Internal pH, Na+ and Ca+ regulation by trimetazidine during cardiac cell acidosis
24. Effects of trimetazidine on membrane damage induced by oxygen free radicals in human cells
25. Beneficial effects of trimetazidine on mitochondrial functions and superoxide production in the cardiac muscle
26. Ambulant myocardial ischemia and its prognostic implications
27. Propranolol in the treatment of angina pectoris
28. Comparison of the new beta adrenoreceptor antagonist nadolol and propranolol in the treatment of angina pectoris